Cargando…

Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial

INTRODUCTION: Exercise is emerging as a therapy in oncology for its physical and psychosocial benefits and potential effects on chemotherapy tolerability and efficacy. However, evidence from randomised controlled trials (RCTs) supporting exercise in patients with borderline resectable or locally adv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Hao, Galvão, Daniel A, Newton, Robert U, Tang, Colin, Dean, Andrew, Jasas, Kevin, Johansson, Mikael, Yusoff, Ian, Spry, Nigel, Taaffe, Dennis R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Pancreatic Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186755/ https://www.ncbi.nlm.nih.gov/pubmed/34099463 http://dx.doi.org/10.1136/bmjgast-2021-000642

Ejemplares similares

Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial
por: Yoh, Kazunori, et al.
Publicado: (2018)

Implication of exercise interventions on sleep disturbance in patients with pancreatic cancer: a study protocol for a randomised controlled trial
por: Yoh, Kazunori, et al.
Publicado: (2018)

A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study
por: Ishii, Hiroshi, et al.
Publicado: (2018)

Clinical impact of physical exercise on sleep disorder as assessed by actigram in patients with chronic pancreatitis: a study protocol for a randomised controlled trial
por: Yoh, Kazunori, et al.
Publicado: (2018)

Social deprivation does not impact on acute pancreatitis severity and mortality: a single-centre study
por: Lim, Wei Boon, et al.
Publicado: (2023)

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
por: Neesse, Albrecht, et al.
Publicado: (2014)

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
por: Alva-Ruiz, Roberto, et al.
Publicado: (2021)

Moderately severe and severe acute pancreatitis : a systematic review of the outcomes in the USA and European Union-5
por: Sarri, Grammati, et al.
Publicado: (2019)

Novel multidisciplinary hub-and-spoke tertiary service for the management of severe acute pancreatitis
por: Nayar, Manu K, et al.
Publicado: (2021)

Incidence of acute pancreatitis among patients with leptospirosis requiring extracorporeal membrane oxygenation (ECMO): a descriptive study
por: Madrigal, Tristan Paulo R, et al.
Publicado: (2023)

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
por: Redegalli, M., et al.
Publicado: (2022)

Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Janssen, Quisette P., et al.
Publicado: (2021)

Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study
por: Lof, Sanne, et al.
Publicado: (2019)

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Maggino, Laura, et al.
Publicado: (2022)

Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
por: Augustinus, Simone, et al.
Publicado: (2023)

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
por: Hill, Colin S., et al.
Publicado: (2022)

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent
por: Hoogstins, Charlotte E. S., et al.
Publicado: (2018)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer
por: Holyoake, Daniel L.P., et al.
Publicado: (2016)

Feasibility and Preliminary Efficacy of a 10-Week Resistance and Aerobic Exercise Intervention During Neoadjuvant Chemoradiation Treatment in Rectal Cancer Patients
por: Singh, Favil, et al.
Publicado: (2018)

Assessing Community Cancer care after insurance ExpanSionS (ACCESS) study protocol
por: Angier, H., et al.
Publicado: (2017)

Exercise intervention and sexual function in advanced prostate cancer: a randomised controlled trial
por: Galvão, Daniel A, et al.
Publicado: (2022)

A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial
por: Galvão, Daniel A, et al.
Publicado: (2009)

Can Exercise Adaptations Be Maintained in Men with Prostate Cancer Following Supervised Programmes? Implications to the COVID-19 Landscape of Urology and Clinical Exercise
por: Lopez, Pedro, et al.
Publicado: (2020)

Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial
por: Newton, Robert U, et al.
Publicado: (2019)

Discussion: Pancreatic Pathology
por: Jensen, Robert T.
Publicado: (1992)

Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study
por: Hsu, Charles C., et al.
Publicado: (2010)

Challenges in the Study of Adjuvant Chemoradiation After Pancreaticoduodenectomy
por: Crane, Christopher H., et al.
Publicado: (2009)

A Case of Gastric Heterotopic Pancreatitis Resected by Laparoscopic Surgery
por: Matsumoto, Takatsugu, et al.
Publicado: (2015)

The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors1
por: Roberts, SE, et al.
Publicado: (2013)

Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis
por: de Rooij, Thijs, et al.
Publicado: (2015)

Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic Cancer
por: Van Rijssen, L. B., et al.
Publicado: (2016)

Risk of subsequent biliary malignancy in patients undergoing cyst excision for congenital choledochal cysts
por: Ohashi, Taku, et al.
Publicado: (2013)

Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study
por: Klompmaker, Sjors, et al.
Publicado: (2018)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center
por: van Roessel, Stijn, et al.
Publicado: (2018)

Prognostic Nomogram for Disease-Specific Survival in Patients with Non-metastatic Ampullary Carcinoma After Surgery
por: Li, Huang-bao, et al.
Publicado: (2019)

Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer
por: Sierzega, Marek, et al.
Publicado: (2016)

Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience
por: Del Chiaro, Marco, et al.
Publicado: (2016)

How to Approach Para-Aortic Lymph Node Metastases During Exploration for Suspected Periampullary Carcinoma: Resection or Bypass?
por: Pranger, Bobby K., et al.
Publicado: (2020)

Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model
por: Latenstein, Anouk E. J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_61h3jc7tk0tqjlak7n2fmqoid9